Zealand Pharma changes financing agreement

Amending an existing deal secures the biotech firm another USD 75m under certain conditions.

Photo: Zealand Pharma / PR

Zealand Pharma reports that it has changed an existing financing agreement with private investment firm Oberland Capital, the firm has announced in a press release.

Last year, Zealand entered a seven-year financing agreement worth up to USD 200m with Oberland Capital, with some of the cash being restricted as to how it could be used.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Further reading

Related articles

Latest news

See all jobs